ADRB2 haplotypes and risk of exacerbations in asthmatic children and young adults treated with long-acting ß2-agonists: A meta-analysis in the PiCA consortium

L. Karimi (Rotterdam, Netherlands), S. Vijverberg (Amsterdam, Netherlands), M. Engelkes (Rotterdam, Netherlands), N. Hernandez-Pacheco (Santa Cruz de Tenerife, Spain), N. Farzan (Amsterdam, Netherlands), P. Soares (Brighton, United Kingdom), B. Francis (Liverpool, United Kingdom), M. Pino-Yanes (Santa Cruz de Tenerife, Spain), C. Eng (San Francisco, United States of America), S. Mukhopadhyay (Brighton, United Kingdom), M. Schieck (Regensburg, Germany), M. Kabesch (Regensburg, Germany), E. Burchard (San Francisco, United States of America), C. Palmer (Dundee, United Kingdom), S. Turner (Aberdeen, United Kingdom), H. Janssens (Rotterdam, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands), K. Verhamme (Rotterdam, Netherlands)

Source: International Congress 2019 – Genes and environment
Session: Genes and environment
Session type: Poster Discussion
Number: 5388
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Karimi (Rotterdam, Netherlands), S. Vijverberg (Amsterdam, Netherlands), M. Engelkes (Rotterdam, Netherlands), N. Hernandez-Pacheco (Santa Cruz de Tenerife, Spain), N. Farzan (Amsterdam, Netherlands), P. Soares (Brighton, United Kingdom), B. Francis (Liverpool, United Kingdom), M. Pino-Yanes (Santa Cruz de Tenerife, Spain), C. Eng (San Francisco, United States of America), S. Mukhopadhyay (Brighton, United Kingdom), M. Schieck (Regensburg, Germany), M. Kabesch (Regensburg, Germany), E. Burchard (San Francisco, United States of America), C. Palmer (Dundee, United Kingdom), S. Turner (Aberdeen, United Kingdom), H. Janssens (Rotterdam, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands), K. Verhamme (Rotterdam, Netherlands). ADRB2 haplotypes and risk of exacerbations in asthmatic children and young adults treated with long-acting ß2-agonists: A meta-analysis in the PiCA consortium. 5388

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: